FOLH1 and pachyonychia congenita: In order to further establish the previously proposed prediction models showing their applicability in different patient populations, we aimed to validate the prediction models estimating pre-test 68Ga-PSMA-11-ligand PET/CT positivity in early biochemical recurrent PC patients after RP in a second, independent patient population.